MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$214,539
Net Income
-$831,227
Net Profit Margin
-387.45%
EPS
-$0.03
Unit: Dollar
Revenue Breakdown
Supply and distribution sales
Sales/access fees
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues, net
214,539
-151,117
635,224
178,238
Cost of implants and other costs
-
-337,010
358,812
0
Cost of goods sold
25,184
-
-
-
Research and development
352,333
305,516
1,004,660
296,860
Selling, general and administrative
775,453
539,369
1,145,353
1,223,321
Impairment of intellectual property
6,374
-
-
-
Depreciation and amortization
11,195
-124,803
71,986
71,977
Total operating expenses
1,170,539
383,072
2,580,811
1,592,158
Other miscellaneous income
-
-
-
104,890
Loss from operations
-956,000
-534,189
-1,945,587
-1,413,920
Interest expense - related parties
135,448
437,947
195,515
164,371
Interest expense, net
31,041
70,009
29,672
36,686
Loss on settlement of debt
-100,000
0
0
-55,000
Grant income
362,597
903,748*
867,130
154,270
Change in fair value of upfront purchase price liability
0
-4,157.5*
-1,785
-394
Change in fair value of royalty liability
0
-330,413.5*
0
33,935
Other miscellaneous income
0
1,747*
496,927
-
Total other income
96,108
62,968
1,137,085
36,644
Loss before provision for income taxes
-859,892
-471,221
-808,502
-1,377,276
Income taxes
0
0
-
0
Net loss
-859,892
-471,221
-808,502
-1,377,276
Non-controlling interest
-28,665
-1,023,773
-1,109,371
-143,858
Net gain attributable to biocorrx inc
-831,227
552,552
-1,917,873
-1,233,418
Basic EPS
0.34
-
-
-
Diluted EPS
-0.03
0.03
-0.11
-0.07
Basic Average Shares
-
-
-
17,011,680
Diluted Average Shares
25,599,642
18,485,888*
18,162,783
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
attributable to biocorrx inc
-$831,227
(1.21%↑ Y/Y)
Non-controlling interest
-$28,665
(-376.77%↓ Y/Y)
Net loss
-$859,892
(-0.95%↓ Y/Y)
Grant income
$362,597
(-12.41%↓ Y/Y)
Loss before
provision for income taxes
-$859,892
(-0.95%↓ Y/Y)
Total other income
$96,108
(11.52%↑ Y/Y)
Supply and
distribution sales
$213,209
Sales/access fees
$1,330
Interest expense -
related parties
$135,448
(184.59%↑ Y/Y)
Loss on settlement of
debt
-$100,000
(24.54%↑ Y/Y)
Interest expense, net
$31,041
(-64.52%↓ Y/Y)
Loss from operations
-$956,000
(-1.92%↓ Y/Y)
Revenues, net
$214,539
(59.04%↑ Y/Y)
Total operating
expenses
$1,170,539
(9.11%↑ Y/Y)
Selling, general and
administrative
$775,453
(-12.49%↓ Y/Y)
Research and development
$352,333
(117.60%↑ Y/Y)
Cost of goods sold
$25,184
Depreciation and
amortization
$11,195
(-54.94%↓ Y/Y)
Impairment of intellectual
property
$6,374
Buy us a coffee
BioCorRx Inc. (BICX)
BioCorRx Inc. (BICX)